Dr. Ananda Basu, MD

Dr. Basu practices at University of Alabama Birmingham Hospital in Birmingham, Alabama.

Dr. Basu's NPI, 1821062647, was assigned on February 16, 2006. Dr. Basu graduated from Mayo Clinic Alix School of Medicine - Rochester in 1985. Dr. Basu's Alabama license number on file is 47222.

Dr. Basu's primary practice is University of Alabama Birmingham Hospital, at 619 19th S St, Birmingham, AL 35211 in Jefferson County. The practice phone is (205) 731-9770.

Dr. Basu's primary practice is University of Alabama Birmingham Hospital in Birmingham, Alabama. Dr. Basu is also affiliated with UAB Hospital. The medical group on file is UAB Medicine. Dmand AI also links Dr. Basu to 1 more hospital, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Basu practices, 2 sites in all. Vendor and product names are available with a free account.

Endocrinology, diabetes and metabolism is Dr. Basu's primary specialty in the NPI Registry, under taxonomy code 207RE0101X. Dr. Basu is board certified in endocrinology, diabetes and metabolism by the American Board of Internal Medicine. Dmand AI has Dr. Basu's licenses on file in 3 states: Alabama, Virginia and Minnesota.

Dmand AI lists chronic diabetes, diabetic emergency and overactive thyroid among the conditions Dr. Basu treats.

CMS data shows 79 Medicare services from Dr. Basu across 3 procedure codes in 2024, for 37 Medicare patients. Medicare paid $3,684 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 37 Medicare patients who saw Dr. Basu in 2024. The largest group is 65 to 74, with 19 patients. 75% of them have chronic kidney disease, and 75% have diabetes. Their average risk score is 2.74, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Basu's median patient age at 42, with 56% women.

In 2024, Dr. Basu wrote 412 Medicare Part D claims for 80 patients. 18% of them were for generic drugs. CMS names the drug for 268 of them, across 10 drugs with 11 or more claims each, at $206,258 in total drug cost. In 2023, CMS named 343 claims across 18 drugs.

Dr. Basu accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 176 papers to Dr. Basu, published from 2003 to 2025. 2015 was the busiest year, with 12. The most frequent topics are Blood Glucose, Insulin and Diabetes Mellitus, Type 2. Dr. Basu has published most often in Am J Physiol Endocrinol Metab. Dr. Basu's most frequent co-authors are Yogish C. Kudva, MBBS, Robert A. Rizza, MD and James Levine, MD.

Dmand AI links Dr. Basu to 7 clinical trials. 1 is still active or recruiting. Conditions studied include Diabetes Mellitus, Type 1, Autoimmune Diseases and Coronary Artery Disease. University of Virginia sponsors the most, 5.

CMS Open Payments shows 20 general payments to Dr. Basu from 11 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 37% of the total. Sanofi and Genzyme US Companies paid the most, $16,239.

Dr. Basu graduated from Mayo Clinic Alix School of Medicine - Rochester in 1985.

Dr. Basu is in network with 14 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 11. Check the plan with the practice before a visit.